279 related articles for article (PubMed ID: 22726603)
1. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
2. Determination of carcinoembryonic antigen and cancer antigen (CA 15-3) in bitches with tumours on mammary gland: preliminary report.
Valencakova-Agyagosova A; Frischova Z; Sevcikova Z; Hajurka J; Lepej J; Szakallova I; Kredatusova G; Nagy V; Ledecky V
Vet Comp Oncol; 2014 Sep; 12(3):205-14. PubMed ID: 22947252
[TBL] [Abstract][Full Text] [Related]
3. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
4. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
5. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
6. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
8. Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma.
Mees G; Vangestel C; Dierckx R; Loomans S; Van Damme N; Peremans K; De Rooster H; Van Goethem B; Pauwels P; Ducatelle R; Van de Wiele C
Res Vet Sci; 2011 Dec; 91(3):e125-8. PubMed ID: 21316722
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
11. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
12. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
13. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
14. A role of ghrelin in canine mammary carcinoma cells proliferation, apoptosis and migration.
Majchrzak K; Pawłowski KM; Orzechowska EJ; Dolka I; Mucha J; Motyl T; Król M
BMC Vet Res; 2012 Sep; 8():170. PubMed ID: 22999388
[TBL] [Abstract][Full Text] [Related]
15. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.
Sánchez-Céspedes R; Millan Y; Guil-Luna S; García-Macías J; Maniscalco L; Iussich S; De Maria R; M de Las Mulas J
J Vet Diagn Invest; 2018 Jan; 30(1):155-160. PubMed ID: 29020879
[TBL] [Abstract][Full Text] [Related]
17. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
18. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
19. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]